I would strongly urge you to dig much further. Check out the bio of Dr Frost, a self made billionaire, its pretty impressive. Personalized medicine is here and OPK is way out in front.
I'll give you a quick recent story about Dr Frost. He was, until very recently, chairman of the board @ Teva. Teva was in talks to buy a small Israeli bio company with some very interesting technology. Dr Frost was in favor of the deal but the CEO of Teva walked away at the last minute. OPK steps in and buys the company for $480 million and after one PII trial of their lead growth hormone drug, PFE steps up and pays $290 mil upfront and another $300 mil + double digits royalties upon approval for the drug. In addition OPK gets a royalty on PFE existing drug until the market transitions over to the new drug. This drug will be submitted for approval in adults in 2016 and in children in 2017.
Why is PFE so sure the new OPK drug would crush theirs? The new OPK drug requires an injection ONCE a week, PFE's is EVERY DAY, game over. The OPK technology extends the half life of the growth hormone by one week. I would encourage you to check out the OPK diet drug almost ready for a PI trial using this same technology. This is just one aspect of the OPK pipeline which is vast and maturing quickly.
Been a shareholder for a full two days here and I'm darn glad to be here. My portfolio badly needed a software stock and it looks like this company is positioned for multi year growth.
IMO, anything health care related that can save the government money is well positioned going forward. On that note, I encourage you to check out OPK (4K blood test), one of the smartest guys in biotech runs the joint. He also owns a controlling position in the company and buys on the open market regularly.
ZG, you are a brilliant man, your insight is truly inspirational, Dr. Frost should hire you to manage his money.
Wait on 2nd thought, Dr. Frost should continue doing what he is doing, HE IS A SELF MAN BILLIONAIRE.
BTW, yesterday's rally was confined to the S&P and it reeks of government manipulation (see the Chinese government buying stock in 149 stocks in the Shanghai index to prop it up). This of course all ends very very badly for investors who chase this fraud.
Is it actually possible for the FDA to approve this drug before their SPA "1 year time line"? I'm just saying,
given the data, the extra PIII study, the safety profile and mounting evidence that the need for this drug is
great, this is as easy cheesy as it gets. Stellar safety and efficacy data means the FDA SHOULD move as
quickly as possible to get this drug into Dr's and patients hands. Do they really need more then 6 months
to approve this drug? I don't think they do and I think that additional PIII study seals the deal, this will turn
out to be another brilliant move by OPK management.
Me thinks the shorts haven't really given much thought to this or anything else really. I'm not saying they don't have time but the window is closing. Once Rayaldee hits the market, 2017 revenue forecasts are going to jump and Wall St is going to pile in. Look a little further ahead into 2018 and the growth hormone drug with PFE will likely hit the market. OPK obviously doesn't have to wait the transition to our new drug to make money, we also get a royalty on the PFE drug it will replace. Our partners over at TSRO will be busy pushing our drug which will result in more revenue. Of course, by this time, the 4K will be in full swing and the BRLI labs will be
humming. Sweet dreams shorts. Who knows, maybe by 2018, COCP will have been absorbed into the fold.
He bought 10's of millions of shares at much lower prices. When the stock was $2 OR $3 he'd be buying
100,000 / 200,000 per day, every single day. He keeps his holdings up because no one but no one is taking
his baby from him. He knows what he has and he knows what its going to be worth and it ain't for sale,
Exactly, follow the smart people who have been there and done that is a pretty simple formula for success. Ray coming in was huge, the clincher because he had the final piece of the puzzle and now it off to trials. The brain power of all these folks connected with OPK is truly incredible.
Proof of concept will send COCP shares higher. If the PI trial is a success wall st will certainly sit up and take notice. You are talking about a drug that can potentially treat all strains of Hep C, that in and of itself is huge. You then have to consider the Rhino virus drug which is due to start trials in 2017. If a Hep C drug is worth $10's of billions in market cap, what is a Hep C and FLU drug worth? You need 5 years to see this all through but I see certainly see a higher share price next year.
COCP has incredible potential but that is all it is right now.
Not sure if most are aware of this but current Hep C drugs can cost $100,000 and up per year. Companies
have been built on one Hep C drug and have market caps north of $50 billion. COCP has the potential to
eclipse all of them. Its still way to early to call but if you dig into the science and look at the bio's of those involved, you realize that failure is not an option. IF this 1st PI trial shows promise then its off to the races for COCP.
Now we know who was behind the takedown of OPK stock price, JPM. Short the #$%$ out of it, take it down,
cover, go long, then put out a positive report and make tons of money.